KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Eli Lilly (LLY) Net Income towards Common Stockholders (2016 - 2025)

Eli Lilly's Net Income towards Common Stockholders history spans 16 years, with the latest figure at $6.6 billion for Q4 2025.

  • For Q4 2025, Net Income towards Common Stockholders rose 50.52% year-over-year to $6.6 billion; the TTM value through Dec 2025 reached $20.6 billion, up 94.9%, while the annual FY2025 figure was $20.6 billion, 94.9% up from the prior year.
  • Net Income towards Common Stockholders reached $6.6 billion in Q4 2025 per LLY's latest filing, up from $5.6 billion in the prior quarter.
  • In the past five years, Net Income towards Common Stockholders ranged from a high of $6.6 billion in Q4 2025 to a low of -$57.4 million in Q3 2023.
  • Average Net Income towards Common Stockholders over 5 years is $2.4 billion, with a median of $1.8 billion recorded in 2022.
  • Peak YoY movement for Net Income towards Common Stockholders: tumbled 103.95% in 2023, then soared 1790.42% in 2024.
  • A 5-year view of Net Income towards Common Stockholders shows it stood at $1.7 billion in 2021, then rose by 12.26% to $1.9 billion in 2022, then increased by 12.98% to $2.2 billion in 2023, then skyrocketed by 101.43% to $4.4 billion in 2024, then soared by 50.52% to $6.6 billion in 2025.
  • Per Business Quant, the three most recent readings for LLY's Net Income towards Common Stockholders are $6.6 billion (Q4 2025), $5.6 billion (Q3 2025), and $5.7 billion (Q2 2025).